Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Athira Pharma Q3 EPS $(0.75) Misses $(0.69) Estimate

Author: Benzinga Newsdesk | November 07, 2024 05:18pm
Athira Pharma (NASDAQ:ATHA) reported quarterly losses of $(0.75) per share which missed the analyst consensus estimate of $(0.69) by 8.7 percent. This is a 13.79 percent increase over losses of $(0.87) per share from the same period last year.

Posted In: ATHA


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist